Author

Caio de Almeida Monteiro

Observed names: Caio De Almeida Monteiro, Caio de A. Monteiro, Caio de Almeida Monteiro1

Institution: Latin American Cooperative Oncology Group (LACOG)

Observed institutions: D’Or Institute for Research and Education, Latin American Cooperative Oncology Group (LACOG)

ORCID: 0009-0004-7728-9778

Observed ORCID: 0009-0004-7728-9778

OpenAlex ID: A5005645659

Durvalumab as consolidation therapy in patients who received chemoradiotherapy for unresectable stage III NSCLC: Real-world data from an expanded access program in Brazil (LACOG 0120)

2024 · Mauro Zukin1, Victor Gondim2, et al. · Jornal Brasileiro de Pneumologia · 4

Current Access to Anaplastic Lymphoma Kinase Testing and Targeted Therapies for Non–Small Cell Lung Cancer in Brazil: Results From a Cross-Sectional Survey (LACOG 1224-GBOT)

2026 · Eldsamira Mascarenhas, Clarissa Baldotto, et al. · JCO Global Oncology · 1

Brief Report: Clinical use, access, and awareness of the utility of ctDNA-based liquid biopsy for NSCLC among oncologists in Latin America – The OMEGA survey.

2026 · Vladmir C. Cordeiro de Lima, Erick F. Saldanha, et al. · JTO Clinical and Research Reports

Impact of liquid biopsy training on real-world testing practices for advanced NSCLC across Latin America: The OMEGA (LACOG 0424/GBOT) survey.

2026 · Leonardo Gil Santana, Erick F. Saldanha, et al. · Journal of Clinical Oncology

Recombinant Human Erythropoietin in Hemolytic Anemia in a Patient With Mechanical Heart Valve

2016 · Caio de Almeida Monteiro, Luís Otávio Cardoso Mocarzel, et al. · International Journal of Cardiovascular Sciences

Works count: 5

Citation count: 5

H-index: 1

I10-index: